If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine.

Aug 4 (Reuters) - Moderna on Tuesday said it has begun its first human trial of an experimental vaccine to protect against ...

Moderna (NasdaqGS:MRNA) has initiated a Phase 1 clinical trial in Canada for its investigational mRNA vaccine targeting ...

Moderna has launched the world's first Phase 1 trial of a Bundibugyo Ebola mRNA vaccine, targeting an Ebola strain that still ...

Moderna has vaccinated the first participants in a trial for a Bundibugyo Ebola vaccine, as the Democratic Republic of Congo ...

The Phase 1 trial of the mRNA vaccine candidate will assess safety, determine the dosage range and identify potential side ...

Moderna launched a human trial of an experimental vaccine to protect against Bundibugyo Ebola strain that has killed more ...

Moderna has started first-in-human testing of its mRNA vaccine against Bundibugyo Ebola virus (BDBV), now causing the ...

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines ...

Moderna begins Ebola vaccine trials in Canada for Bundibugyo strain. Phase 1 assesses safety, dosage, and side effects.

Novo and Lilly earnings are out, Aurora Therapeutics slashing staff, and more biotech news from The Readout ...

TORONTO — Health Canada has authorized Moderna to conduct a clinical trial on a new mRNA vaccine that targets the form of ...